SCHEMBL9813604

SCHEMBL9813604

CN1C(=O)CSC1=CC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ PSMD14 O00487 1/20 0.48
▸ KMT2A Q03164 8/20 0.46
▸ MEN1 O00255 7/20 0.46
▸ MAPT P10636 6/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 4/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ POLB P06746 1/20 0.42
▸ THRB P10828 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ OPRM1 P35372 1/20 0.40
▸ OPRD1 P41143 1/20 0.40
▸ EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9813602 1.00 ALDH1A1 (0.57) ALDH1A1TDP1PSMD14KMT2AMEN1
SCHEMBL9813589 0.86 ALDH1A1 (0.66) ALDH1A1TDP1PSMD14KMT2AMEN1
SCHEMBL9813586 0.86 ALDH1A1 (0.66) ALDH1A1TDP1PSMD14KMT2AMEN1
SCHEMBL9813544 0.85 ALDH1A1 (0.56) ALDH1A1TDP1PSMD14KMT2AMEN1
SCHEMBL9813543 0.85 ALDH1A1 (0.56) ALDH1A1TDP1PSMD14KMT2AMEN1
SCHEMBL9813551 0.81 ALDH1A1 (0.59) ALDH1A1TDP1PSMD14KMT2AMEN1
SCHEMBL9813552 0.81 ALDH1A1 (0.59) ALDH1A1TDP1PSMD14KMT2AMEN1
SCHEMBL9813545 0.80 ALDH1A1 (0.71) ALDH1A1TDP1PSMD14MAPTSMN1; SMN2
SCHEMBL9813546 0.80 ALDH1A1 (0.71) ALDH1A1TDP1PSMD14MAPTSMN1; SMN2
SCHEMBL10849287 0.77 ALDH1A1 (0.53) ALDH1A1TDP1PSMD14KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP disclosed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US disclosed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP disclosed
Send feedback